Sign In
Buy MRTX
$58.70
+0 (+0%)
At Close: Apr 19, 2024
Mirati (MRTX) Up 4.1% Since Last Earnings Report: Can It Continue?
03:31pm, Saturday, 06'th Jun 2020
Mirati (MRTX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Mirati Therapeutics to Present at 41st Annual Goldman Sachs Global Healthcare Conference
02:00pm, Friday, 05'th Jun 2020
SAN DIEGO, June 5, 2020 /PRNewswire via COMTEX/ --
SAN DIEGO, June 5, 2020 /PRNewswire/ -- Mirati Therapeutics, Inc. (NASDAQ: MRTX), a clinical-stage...
Mirati Therapeutics to Present at 41st Annual Goldman Sachs Global Healthcare Conference
01:00pm, Friday, 05'th Jun 2020
Mirati Therapeutics, Inc. (NASDAQ: MRTX), a clinical-stage targeted oncology company, will participate in the upcoming 41st Annual Goldman Sachs Global Healthcare Conference on Thursday, June 11, 2020
Chip Stocks Rally Despite US–China Tensions
01:45pm, Wednesday, 03'rd Jun 2020
Semiconductor stocks have been at the forefront of the market's pandemic recovery. Trade industry-leading names with these tactical ideas.
Hedge Funds Are Nibbling On Mirati Therapeutics, Inc. (MRTX)
12:59am, Wednesday, 03'rd Jun 2020
The financial regulations require hedge funds and wealthy investors that exceeded the $100 million equity holdings threshold to file a report that shows their positions at the end of every quarter. Ev
Merck's (MRK) Management Presents at Oncology Event ASCO 2020 Conference (Transcript)
12:50am, Wednesday, 03'rd Jun 2020
Merck & Co., Inc. (NYSE:MRK) Oncology Event ASCO 2020 Conference June 2, 2020 2:00 PM ET Company Participants Peter Dannenbaum – Vice President, Investor Re
Here is What Hedge Funds Think About Qorvo Inc (QRVO)
01:07pm, Monday, 01'st Jun 2020
Before we spend countless hours researching a company, we like to analyze what insiders, hedge funds and billionaire investors think of the stock first. This is a necessary first step in our investmen
Xconomy: Forma Therapeutics Eyes IPO to Advance Sickle Cell, Prostate Cancer Drugs
02:30am, Saturday, 30'th May 2020
Forma Therapeutics has developed a pipeline of small molecules aimed at rare blood disorders and cancers, but it aims to advance two---investigational
Anggota Komisi VI mengapresiasi Krakatau Steel berhasil bukukan laba
06:42am, Friday, 29'th May 2020
Anggota Komisi VI DPR RI Deddy Yevri Sitorus mengapresiasi PT Krakatau Steel yang berhasil membukukan laba sesuai laporan keuangan yang diaudit auditor ...
RGENIX Shows Clinical Activity of Novel Agent RGX-202 in Patients with KRAS Mutant Colorectal Cancer in Phase 1 Trial
12:00am, Friday, 29'th May 2020
RGENIX, a clinical stage biopharmaceutical company, shows clinical activity of novel agent RGX-202 in patients with KRAS mutant colorectal cancer.
Founders’ story: Libera Bio
07:30pm, Thursday, 28'th May 2020
In an interview with MedCity News, the founder and CSO of Spanish biotech startup Libera Bio talked about her company's ambitions to apply its precision medicine technologies for the treatment of diff
Biocept Inc. (NASDAQ: BIOC) Q1 2020 Earnings Call Transcript | AlphaStreet
01:50pm, Tuesday, 26'th May 2020
Final earnings conference call transcript of Biocept Inc. - BIOC stock
Xconomy: Bio Roundup: mRNA Vaccine Data, Rise of Rallybio, Roche’s Protein Play & More
02:40pm, Friday, 22'nd May 2020
As the nation started to reopen this week following two months of closed businesses and stay-at-home orders, public health officials and economists
Mirati Therapeutics Appoints Joseph A. Leveque, M.D. As Chief Medical Officer
08:15pm, Monday, 18'th May 2020
Mirati Therapeutics, Inc. (NASDAQ: MRTX), a clinical-stage targeted oncology company, today announced that Joseph Leveque, M.D. has been named Chief Medical Officer effective May 18, 2020. Isan Chen,
